12650-70-3 Usage
Uses
Used in Pharmaceutical Industry:
(3-[4-(hexopyranosyloxy)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]amino-4,5,6-trihydroxycyclohex-1-en-1-yl)methyl hexopyranoside is used as a pharmaceutical candidate for its potential biological activity and involvement in cellular processes. The presence of multiple hydroxyl groups and sugar moieties may contribute to its interactions with biopolymers and macromolecules, making it a promising candidate for drug development.
Used in Drug Delivery Systems:
In the field of drug delivery, (3-[4-(hexopyranosyloxy)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]amino-4,5,6-trihydroxycyclohex-1-en-1-yl)methyl hexopyranoside can be employed as a carrier molecule for targeted drug delivery. Its hydrophilic nature and potential reactivity with other molecules may allow for the development of novel drug delivery systems that improve the bioavailability and therapeutic outcomes of various pharmaceutical agents.
Used in Biochemical Research:
(3-[4-(hexopyranosyloxy)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]amino-4,5,6-trihydroxycyclohex-1-en-1-yl)methyl hexopyranoside can be utilized in biochemical research for studying the interactions between glycosides and biopolymers or macromolecules. Its complex structure and potential reactivity make it a valuable tool for understanding the mechanisms of cellular processes and the development of new therapeutic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 12650-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,2,6,5 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 12650-70:
(7*1)+(6*2)+(5*6)+(4*5)+(3*0)+(2*7)+(1*0)=83
83 % 10 = 3
So 12650-70-3 is a valid CAS Registry Number.
12650-70-3Relevant academic research and scientific papers
Synthetic Studies on Antiobiotic Validamycins. Part 14. Total Syntheses of (+)-Validamycins C, D and F
Miyamoto, Yasunobu,Ogawa, Seiichiro
, p. 2121 - 2128 (2007/10/02)
(+)-Validamycins C and F were first completely synthesised by use of a common blocked derivative 5 of (+)-validoxylamine A.The diols 6 and 7, obtained by acid hydrolysis of 5, were appropriately protected to give the aglycones 17, 25 and 30, which were co
